SERPINF1 and cancer: The induction of neuroendocrine differentiation, however, may not be advantageous for patients with prostate cancer because PEDF expression is negatively regulated by testosterone [12], and high PEDF levels due to androgen ablation in cancer may cause expansion of the neuroendocrine component and influence both prostate development and prostate cancer progression [140].